3SBio Inc Sustainability Reports
3SBio Inc. is a leading biotechnology company focused on researching, developing, manufacturing, and marketing biopharmaceutical products primarily in China. Its core commercialized portfolio addresses major markets in nephrology, oncology, supportive cancer care, inflammation, and dermatology.
Sector: Manufacturing
Country: China
Exchange: Hong Kong Stock Exchange
LEI: 529900P0TQC1E9Y7FN31
FIGI: BBG009BKGLT8
23 reports from 2015 to 2025
